{"status":"ok","message-type":"event-list","message":{"next-cursor":"55f33031-3574-4572-aca1-6da299e93815","total-results":34,"items-per-page":1000,"events":[{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2017-09-16T23:02:11Z","subj_id":"http:\/\/twitter.com\/MolMicroEditors\/statuses\/909190706434134016","id":"3249d3ed-06e7-47ba-b32f-b35871fedf94","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20170916-twitter-a0e3acff-fb4e-434e-b04d-5f0887d5cd9d","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"http:\/\/twitter.com\/MolMicroEditors\/statuses\/909190706434134016","title":"Tweet 909190706434134016","issued":"2017-09-16T23:02:11.000Z","author":{"url":"http:\/\/www.twitter.com\/MolMicroEditors"},"original-tweet-url":"http:\/\/twitter.com\/MolMicroEditors\/statuses\/909190706434134016","original-tweet-author":null,"alternative-id":"909190706434134016"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","url":"http:\/\/onlinelibrary.wiley.com\/wol1\/resolve\/doi?DOI=10.1046%2Fj.1365-2958.2002.02779.x#.Wb2sjlj-I9U.twitter"},"timestamp":"2017-09-16T23:03:58Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2017-09-16T23:16:22Z","subj_id":"http:\/\/twitter.com\/MBlokesch\/statuses\/909194278164942848","id":"19ab83c1-1064-4771-b043-d7139e70a4aa","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20170916-twitter-b3e3e057-0e63-4dcf-a05c-5d8a07085b2f","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"http:\/\/twitter.com\/MBlokesch\/statuses\/909194278164942848","title":"Tweet 909194278164942848","issued":"2017-09-16T23:16:22.000Z","author":{"url":"http:\/\/www.twitter.com\/MBlokesch"},"original-tweet-url":"http:\/\/twitter.com\/MolMicroEditors\/statuses\/909190706434134016","original-tweet-author":"http:\/\/www.twitter.com\/MolMicroEditors","alternative-id":"909194278164942848"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","url":"http:\/\/onlinelibrary.wiley.com\/wol1\/resolve\/doi?DOI=10.1046%2Fj.1365-2958.2002.02779.x#.Wb2sjlj-I9U.twitter"},"timestamp":"2017-09-16T23:30:55Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2017-09-17T13:50:42Z","subj_id":"http:\/\/twitter.com\/maxgabgut\/statuses\/909414309435969537","id":"64d5d2a8-4607-4a87-ab95-0b72ab7b6371","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20170917-twitter-79989d6f-e940-4b64-afe7-6a76a70ba07d","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"http:\/\/twitter.com\/maxgabgut\/statuses\/909414309435969537","title":"Tweet 909414309435969537","issued":"2017-09-17T13:50:42.000Z","author":{"url":"http:\/\/www.twitter.com\/maxgabgut"},"original-tweet-url":"http:\/\/twitter.com\/maxgabgut\/statuses\/909414309435969537","original-tweet-author":null,"alternative-id":"909414309435969537"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","url":"http:\/\/onlinelibrary.wiley.com\/wol1\/resolve\/doi?DOI=10.1046%2Fj.1365-2958.2002.02779.x#.Wb2sjlj-I9U.twitter"},"timestamp":"2017-09-17T13:52:42Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2017-09-17T13:51:04Z","subj_id":"http:\/\/twitter.com\/sil_057\/statuses\/909414402276888576","id":"33bd6b21-4e72-4bc9-85e9-f144eb211529","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20170917-twitter-60e66b59-7db1-4990-a2f9-bb27692ecf63","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"http:\/\/twitter.com\/sil_057\/statuses\/909414402276888576","title":"Tweet 909414402276888576","issued":"2017-09-17T13:51:04.000Z","author":{"url":"http:\/\/www.twitter.com\/sil_057"},"original-tweet-url":"http:\/\/twitter.com\/maxgabgut\/statuses\/909414309435969537","original-tweet-author":"http:\/\/www.twitter.com\/maxgabgut","alternative-id":"909414402276888576"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","url":"http:\/\/onlinelibrary.wiley.com\/wol1\/resolve\/doi?DOI=10.1046%2Fj.1365-2958.2002.02779.x#.Wb2sjlj-I9U.twitter"},"timestamp":"2017-09-17T14:01:59Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2017-09-17T18:41:03Z","subj_id":"http:\/\/twitter.com\/MolMicroEditors\/statuses\/909487381061005312","id":"6c793fef-91e5-4dd4-95df-b0fd1d9ed51a","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20170917-twitter-b4c74eb7-4fd0-48cd-b509-1b1d5613bbd7","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"http:\/\/twitter.com\/MolMicroEditors\/statuses\/909487381061005312","title":"Tweet 909487381061005312","issued":"2017-09-17T18:41:03.000Z","author":{"url":"http:\/\/www.twitter.com\/MolMicroEditors"},"original-tweet-url":"http:\/\/twitter.com\/maxgabgut\/statuses\/909414309435969537","original-tweet-author":"http:\/\/www.twitter.com\/maxgabgut","alternative-id":"909487381061005312"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","url":"http:\/\/onlinelibrary.wiley.com\/wol1\/resolve\/doi?DOI=10.1046%2Fj.1365-2958.2002.02779.x#.Wb2sjlj-I9U.twitter"},"timestamp":"2017-09-17T18:42:58Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2017-09-18T15:49:31Z","subj_id":"http:\/\/twitter.com\/cbuch2\/statuses\/909806602097762304","id":"17052668-b8ae-494d-afe6-8da7e825f0c3","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20170918-twitter-19f9a82b-cff3-47ef-9732-fb53c165a751","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"http:\/\/twitter.com\/cbuch2\/statuses\/909806602097762304","title":"Tweet 909806602097762304","issued":"2017-09-18T15:49:31.000Z","author":{"url":"http:\/\/www.twitter.com\/cbuch2"},"original-tweet-url":"http:\/\/twitter.com\/MolMicroEditors\/statuses\/909190706434134016","original-tweet-author":"http:\/\/www.twitter.com\/MolMicroEditors","alternative-id":"909806602097762304"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","url":"http:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2958.2002.02779.x\/abstract;jsessionid=A6E15706CFA39AA94076CD61D87ADA58.f04t02"},"timestamp":"2017-09-18T15:50:07Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2004-03-18T00:00:00Z","subj_id":"https:\/\/lens.org\/010-089-622-447-170","id":"75796677-08bc-27b3-4271-82f2ea0e395c","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Search report","work_type_id":"patent","title":"Therapeutic Tuberculosis Vaccines","pid":"https:\/\/lens.org\/010-089-622-447-170","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T00:34:55Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-10-26T00:00:00Z","subj_id":"https:\/\/lens.org\/103-322-747-429-566","id":"39cd1e83-e260-66af-d360-2bf9b205fe2a","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Improved Tuberculosis Vaccines","pid":"https:\/\/lens.org\/103-322-747-429-566","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-10T01:13:13Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-12-27T00:00:00Z","subj_id":"https:\/\/lens.org\/105-312-310-690-888","id":"62217a49-0072-d81f-28ab-c7f271c709d1","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Peptide Prodrugs","pid":"https:\/\/lens.org\/105-312-310-690-888","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T01:43:44Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-10-26T00:00:00Z","subj_id":"https:\/\/lens.org\/117-827-894-270-913","id":"667099ad-e1a1-d889-f144-595eea84566b","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Improved Tuberculosis Vaccines","pid":"https:\/\/lens.org\/117-827-894-270-913","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-10T04:58:10Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-10-23T00:00:00Z","subj_id":"https:\/\/lens.org\/118-151-911-772-114","id":"6e572d23-5adf-5c01-ee7e-8a11db277a80","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase","pid":"https:\/\/lens.org\/118-151-911-772-114","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T05:02:54Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-04-22T00:00:00Z","subj_id":"https:\/\/lens.org\/119-349-464-222-291","id":"fb8c21a2-6e54-3365-a621-b6a2e091cff7","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase","pid":"https:\/\/lens.org\/119-349-464-222-291","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T05:21:41Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2013-03-26T00:00:00Z","subj_id":"https:\/\/lens.org\/129-384-637-788-442","id":"1d0fd20b-d221-87e3-6e9d-2dcf47ac9340","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Mycobacterial Antigens Expressed Under Low Oxygen Tension","pid":"https:\/\/lens.org\/129-384-637-788-442","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T07:56:19Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2008-07-01T00:00:00Z","subj_id":"https:\/\/lens.org\/136-717-878-362-713","id":"683a42aa-7d12-b07e-efd5-9c8595f0b02f","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Mycobacterial Antigens Expressed During Latency","pid":"https:\/\/lens.org\/136-717-878-362-713","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T09:49:52Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-08-23T00:00:00Z","subj_id":"https:\/\/lens.org\/152-087-523-409-208","id":"a4be8339-cda6-603a-f6c0-346f4eb4e334","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Mycobacterial Antigens Expressed During Latency","pid":"https:\/\/lens.org\/152-087-523-409-208","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T13:48:20Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-12-01T00:00:00Z","subj_id":"https:\/\/lens.org\/156-439-833-050-343","id":"62e67a7b-ac98-f7e4-6c56-a5e4f070cf75","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Modified Antigens","pid":"https:\/\/lens.org\/156-439-833-050-343","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T14:55:04Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2009-08-04T00:00:00Z","subj_id":"https:\/\/lens.org\/164-432-012-713-208","id":"fb62d337-5f40-c83f-dfda-468e7f3933e9","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Peptide Antagonists For Inhibiting Heat Shock Protein (Hsp 16.3) Of Mycobacterium Tuberculosis","pid":"https:\/\/lens.org\/164-432-012-713-208","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T17:03:33Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-09-13T00:00:00Z","subj_id":"https:\/\/lens.org\/165-732-185-498-367","id":"4e69e8be-feb2-f356-24a8-3e86574421bc","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Mycobacterial Antigens Expressed Under Low Oxygen Tension","pid":"https:\/\/lens.org\/165-732-185-498-367","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T17:26:03Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2013-10-15T00:00:00Z","subj_id":"https:\/\/lens.org\/017-142-437-462-007","id":"74032ad9-eae7-f6db-e415-79556519fa2a","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Vaccines Comprising Tb10.4","pid":"https:\/\/lens.org\/017-142-437-462-007","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T19:02:48Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2016-03-01T00:00:00Z","subj_id":"https:\/\/lens.org\/176-026-531-368-129","id":"c28b20a1-e6a1-9336-df2e-06569f2cf0a5","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Methods For Treatment Of Bacterial Infections","pid":"https:\/\/lens.org\/176-026-531-368-129","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T20:21:42Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-01-13T00:00:00Z","subj_id":"https:\/\/lens.org\/183-203-956-085-413","id":"4ef0fa79-86ef-80bc-9c2e-8c27bacb98f0","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Modified Tuberculosis Antigens","pid":"https:\/\/lens.org\/183-203-956-085-413","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T22:23:00Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2010-03-17T00:00:00Z","subj_id":"https:\/\/lens.org\/184-962-320-770-54X","id":"7ba3a5c9-713b-102b-67ab-6c57333dd30e","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase","pid":"https:\/\/lens.org\/184-962-320-770-54X","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-10T22:53:10Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2013-02-05T00:00:00Z","subj_id":"https:\/\/lens.org\/197-939-749-160-273","id":"23891275-2364-4d32-b5de-4ebfa1da4d53","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Immunogenic Compositions Against Tuberculosis","pid":"https:\/\/lens.org\/197-939-749-160-273","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T02:33:47Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-01-24T00:00:00Z","subj_id":"https:\/\/lens.org\/198-338-940-509-683","id":"2edb803a-c43f-5679-9591-4d5eb46b4928","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase","pid":"https:\/\/lens.org\/198-338-940-509-683","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T02:40:36Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2013-03-19T00:00:00Z","subj_id":"https:\/\/lens.org\/046-541-141-011-979","id":"0456013e-29c3-805b-c553-50ce2b0207af","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Mycobacterial Antigens Expressed During Latency","pid":"https:\/\/lens.org\/046-541-141-011-979","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T10:01:09Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-06-28T00:00:00Z","subj_id":"https:\/\/lens.org\/004-680-394-871-586","id":"f0679e16-2bc4-5140-9bf9-21aebd3f6bc5","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase","pid":"https:\/\/lens.org\/004-680-394-871-586","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T10:05:25Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-10-16T00:00:00Z","subj_id":"https:\/\/lens.org\/050-801-263-752-25X","id":"6ece9fc2-812e-5524-7dfe-2d1130b5e6fa","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"In Vitro Model Of Latent Mycobacterial Infection","pid":"https:\/\/lens.org\/050-801-263-752-25X","jurisdiction":"AU"},"source_id":"cambia-lens","timestamp":"2017-11-11T11:07:49Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2007-11-15T00:00:00Z","subj_id":"https:\/\/lens.org\/067-375-138-863-733","id":"2b361e7c-ab06-40b2-0b2f-0ec4e1db7680","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Search report","work_type_id":"patent","title":"Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase","pid":"https:\/\/lens.org\/067-375-138-863-733","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T15:25:54Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-12-29T00:00:00Z","subj_id":"https:\/\/lens.org\/072-801-141-526-172","id":"eb131cdf-3b05-1545-49d0-33af6711ba51","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Immunogenic Compositions Against Tuberculosis","pid":"https:\/\/lens.org\/072-801-141-526-172","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T16:52:48Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2003-10-16T00:00:00Z","subj_id":"https:\/\/lens.org\/091-997-015-141-032","id":"829724bf-7ad0-46aa-7f0e-49e11608a5fd","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Search report","work_type_id":"patent","title":"Mycobacterial Antigens Expressed During Latency","pid":"https:\/\/lens.org\/091-997-015-141-032","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T22:18:43Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2008-11-06T00:00:00Z","subj_id":"https:\/\/lens.org\/092-926-769-628-38X","id":"342b6b21-1fbe-0f7d-fd9d-50f51e4411b2","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"In Vitro Model Of Latent Mycobacterial Infection","pid":"https:\/\/lens.org\/092-926-769-628-38X","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T22:34:32Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-09-06T00:00:00Z","subj_id":"https:\/\/lens.org\/093-555-600-961-132","id":"16932749-293e-a53e-f1d4-a041980471a2","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"In Vitro Model Of Latent Mycobacterial Infection","pid":"https:\/\/lens.org\/093-555-600-961-132","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T22:45:24Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"28276d12-b320-41ba-9272-bb0adc3466ff","occurred_at":"2019-09-29T19:31:08.000Z","subj_id":"https:\/\/doi.org\/10.1371\/journal.pone.0001502","id":"d31e1bfe-9ea2-48c5-837e-b7788b26dcf2","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","subj":{"pid":"https:\/\/doi.org\/10.1371\/journal.pone.0001502","work_type_id":"ScholarlyArticle"},"message_action":"create","source_id":"datacite","obj":{},"timestamp":"2019-09-30T02:16:57Z","relation_type_id":"references"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2958.2002.02779.x","source_token":"28276d12-b320-41ba-9272-bb0adc3466ff","occurred_at":"2019-09-29T19:31:08.000Z","subj_id":"https:\/\/doi.org\/10.1371\/journal.pone.0001502","id":"55f33031-3574-4572-aca1-6da299e93815","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","subj":{"pid":"https:\/\/doi.org\/10.1371\/journal.pone.0001502","work_type_id":"ScholarlyArticle"},"message_action":"create","source_id":"datacite","obj":{},"timestamp":"2019-09-30T02:17:07Z","relation_type_id":"references"}]}}